lapatinib has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, O; Fouad, M | 1 |
| Awada, A; Azim, HA; Metzger Filho, O; Saini, KS | 1 |
2 review(s) available for lapatinib and Cholera Infantum
| Article | Year |
|---|---|
Risk of selected gastrointestinal toxicities in breast cancer patients treated with regimens containing lapatinib; a pooled analysis of randomized controlled studies.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Monitoring; Female; Gastrointestinal Diseases; Humans; Lapatinib; Quinazolines; Randomized Controlled Trials as Topic; Risk | 2014 |
Prevention and management of major side effects of targeted agents in breast cancer.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Breast; Breast Neoplasms; Cardiovascular Diseases; Female; Gastrointestinal Diseases; Humans; Lapatinib; Molecular Targeted Therapy; Quinazolines; Skin Diseases; Trastuzumab | 2012 |